University of Missouri School of Medicine MU Health School of Medicine
lentz-k

Kathy J. Lentz, MD, FACS

Clinical Instructor

Background

  • College/Medical School: University of Missouri – Kansas City
  • Internship: Internal Medicine – St. Luke’s Hospital Kansas City
  • Outside Interests: MIZZOU sports; plein air painting; art history; travel

Medical Practice

  • October 1985 to April 1987 Tri-County Eye Center
    800 East Fifth Street, Suite 115
    Washington, MO 63090
  • January 1986 to present Clinical Assistant Professor of Ophthalmology
    University of Missouri- Columbia
    Mason Institute of Ophthalmology
    One Hospital Drive
    Columbia, Missouri 65212
  • April 1987 to July 2012 Washington Eye Surgeons
    Kathy J. Lentz, M.D., F.A.C.S.
    851 East Fifth Street, Suite 116
    Washington, Missouri 63090

Honors and Scholarships

  • 1974-1976 Missouri Curators Scholar
  • 1974-1977 March of Dimes Health Science Scholar
  • 1982 Association for Research in Vision and Ophthalmology Scholar
  • 2004 Spirit of Mercy Humanitarian Award

Certification and Licensure

  • 1981 Certification National Board of Medical Examiners
  • 1981 Licensure Missouri
  • 1986 Certification American Board of Ophthalmology

Education

  • 1974 Diploma Neosho High School
  • 1980 B.A.- M.D. University of Missouri- Kansas City
    School of Medicine
    Kansas City, Missouri

Post-Graduate Training

  • May 1978 Preceptorship Health Care Preceptorship
    Israel and Greece
  • 1980-1981 Internship St. Luke’s Hospital
    Internal Medicine Kansas City, Missouri
  • 1982 Basic Science Course
    Stanford University
    Palo Alto, California
  • 1982-1985 Residency Institute of Ophthalmology
    University of Missouri
    Columbia, Missouri

Memberships

  • 1977-1978 Student Representative
    Jackson County Medical Society
    Kansas City, Missouri
  • 1981-Present Association for Research in Vision and Ophthalmology
  • 1982-Present American Medical Association
  • 1985-Present Missouri Ophthalmology Society, Inc.
  • 1985-Present Missouri State Medical Association
  • 1985-Present Franklin, Gasconade, and Warren County Medical Society

Fellowships

  • 1985 Member American Association of Ophthalmology
  • 1986 Fellow American Association of Ophthalmology
  • 1991 Fellow American College of Surgeons

Medical Mission Work

  • February 1992 Project Orbis
    Dhaka, Bangladesh
  • November 1992 Project Orbis
    Changsha, China
  • October 1993 Project Orbis
    Tirana, Albania
  • November 1994 Project Orbis
    Khartoum, Sudan
  • October 1995 Project Orbis
    Dalian, China
  • 1996 Project Orbis
    Havana, Cuba
  • February 1996 Washington Medical/Dental Mission
    Honduras
  • May 1998 Operation Blessing/Flying Hospital
    Brasilia, Brazil
  • August 1998 Operation Blessing/Flying Hospital
    Cochambomba, Bolivia
  • September 1998 Palestinian Children’s Relief Fund
    Gaza and West Bank, Palestine
  • November 1998 Project Orbis
    Chongqing, China
  • January 1999 Project Orbis
    Ciego de Avila, Cuba
  • March 1999 Washington Medical/Dental Mission
    Honduras
  • August 1999 Lighthouse for Christ
    Mombasa, Kenya
  • October 1999 Project Orbis
    Ulan Bataar, Mongolia
  • March 2000 Mercy Ships
    La Union, El Salvador
  • February 2001 Project Orbis
    Chitrakoot, India
  • February 2003 Mercy Ships
    Dominican Republic
  • July 2004 Project Orbis
    Paraguay
  • March 2005 Deseret International Foundation
    Damascus and Aleppo, Syria
  • November 2007 Beirut, Lebanon

Research 

  1. “The Efficacy and Safety of Oxymetazoline HCL 0.25% vs. Placebo Vehicle in SubjectsWith Allergic Conjunctivitis”, 91-08, Pfizer Pharmaceuticals, 1991.
    Principle Investigator: William E. Stricker
    Co-Investigators: Mark Vandewalker, Kathy J. Lentz, Vernon E. Falkenhain, Eamil A.
    Stricker
    Clinical Research Investigator: Patrick W. Welsh
  2. “An Environmental Capture Clinical Study evaluating the Ocular Safety, Comfort,
    Efficacy, and Onset of Action of Acular Ophthalmic Solution Compared with Vehicle in
    Relief of Allergic Signs and Symptoms in Subjects with Seasonal Allergic Conjuctivitis”,
    92-12, Allergan Pharmaceuticals, 1992.
    Principle Investigator: William B. Stricker
    Co-Investigators: Mark L. Vandewalker, Eamil A. Stricker, Kathy J. Lentz,
    Vernon Falkenhain
    Clinical Research Coordinator: Patrick W. Welsh
  3. “Assessment of the Duration of Action of Levocabastine in the Antigen Challenge Model
    Of Acute Allergic Conjuctivitis: Three Hour Antigen Rechallenge”, #LE92/003, IOLAB
    Corporation, 1992.
    Principle Investigator: William B. Stricker
    Co-Investigators: Mark L. Vandewalker, Kathy J. Lentz, Vernon Falkenhain, Micheal
    Korenfeld
    Clinical Research Coordinator: Patrick W. Welsh
  4. “A Randomized, Double-Blind, Parallel Group, Comparative Trial Assessing the Long Term Safety of Inhaled Fluticasone Propionate Rotadisks via Diskhaler 50 mcg BID and 100 mcg BID vs. Placebo in Patients Aged Four to Eleven Years with Mild to Moderate Chronic Asthma”. FLD-220, Glaxo, Inc.
    Principle Investigator: Mark L. Vandewalker
    Co-Investigators: William E. Stricker, Eamil A. Stricker, Kathy J. Lentz, Michael S.
    Korenfeld, David E. Falkenhain
    Clinical Research Coordinator: Patrick W. Welsh
  5. “Effects of Naphazoline (0.025%) Pheniramine (0.3%) in Combination as Compared to
    Vehicle Control, Naphazoline (0.25%) and Pheniramine (0.3%) In the Allergen Challenge Model of Acute Allergic Conjunotivitis”, AK001-02, Akorn, Inc. 1993
    Principle Investigator: Mark L. Vandewalker
    Co-Investigators: William E. Stricker, Kathy J. Lentz, Michael Korenfeld, Vernon E.
    Falkenhain, David E. Falkenhain
    Clinical Research Coordinator: Patrick W. Welsh

Research Experience

  1. 1981-1982 Research Fellowship
    University of Missouri
    Columbia, Missouri
    Sponsors: Dr. R.P. Burns
    Dr. L. Feeney-Burns

Publications

  1. Burns RP, Lentz K, Hook RR, Berkelhammer J; “Spontaneous Animal Model of Band Keratopathy in the Pig”. Suppl Invest Ophthalmol 22, 3:20, 1983
  2. Lentz KJ, Burns RP, Berkelhammer J, Hook RR, Loeffer K; “Malignant Melanoma Regression with Uveal Melanocyte Destruction and Blindness”. Suppl Invest Ophthalmol 22, 3:261, 1983 (ARVO 1982)
  3. Lentz KJ, Berkelhammer J, Crane J, Burns RP, Hook RR; “Uveal Melanocyte Destruction Associated with Increased Leukocyte Reactivity During Spontaneous Melanoma Regression”. Suppl Invest Ophthalmol 24, 3:286, 1983 (ARVO 1983)
  4. Lentz KJ, Burns RP, Loeffler K, Feeney-Burns L, Berkelhammer J, Hook RR; “Uveitis Caused By Cytoxic Immune Response to Cutaneous Malignant Melanoma in Swine: Destruction of Uveal Melanocytes during Tumor Regression”. Invest Ophthal Vis Sci 24: 1063-9, 1983
  5. Burns RP, Feeney-Burns L, Lentz KJ, Loeffler K, Hook RR, Berkelhammer J, Oxenhandler RW, Middleton CC: “Eye Changes in Cutaneous Malignant Melanomas in Swine”. In: Tabbara KF, Cell R, eds. Animal Models of Ocular Diseases. Springfield: CC Thomas 145-146, 1984

Presentations

  1. 1982 Association for Research in Vision and Ophthalmology
    Sarasota, FL, “Malignant Melanoma Regression with Uveal Melanocyte
    Destruction and Blindness”
  2. 1983 Association for Research in Vision and Ophthalmology
    Sarasota, FL, “Increased Leukocyte Reactivity in Spontaneous Melanoma
    Regression”
 
Printer Friendly Secure Secure        
Follow us on Twitter!   Facebook   YouTube Videos   Instagram   Pinterest  
Website created and maintained by the Office of Communications. Contact the MU School of Medicine.
Revised: June 21, 2013 - Copyright © 2014 - Curators of the University of Missouri. All rights reserved. DMCA and
other copyright information. An equal opportunity/access/affirmative action/pro-disabled and veteran employer.